Gujarat Kidney IPO Analyzed

Gujarat Kidney and Super Speciality’s stock is currently trading slightly higher than its initial offering price. Shares were at Rs 115.25 at 10:20 IST, which is a 1.10% premium to the price it started at, Rs 114. This means investors are paying a little bit more for the stock than when it first came out. The stock initially jumped to Rs 120.75, a 5.92% premium, showing a strong start.

Key Points

• Stock price: Rs 115.25, a 1.10% premium to the issue price.
• Initial debut: Rs 120.75, a 5.92% premium to the issue price.
• Heavy trading: Over 11.13 million shares have already been bought and sold.
• Strong Subscription: The IPO was 5.21 times oversubscribed.
• Key Funding: Proceeds used for hospital acquisition, equipment, and debt repayment.
• Promoter Ownership: Promoters control 99.1% of the company’s shares post-IPO.

The IPO was held between December 22nd and December 24th, 2025, with a price range of Rs 108 to Rs 114. Investors were really interested in buying shares, as it was 5.21 times oversubscribed. This means five times more shares were applied for than were available.

The company is raising money for a few important things. It wants to buy a hospital called Parekhs in Ahmedabad, pay off some debts, and even buy fancy robots for a hospital in Vadodara. They also need money for general business stuff.

The people running the company are Dr. Pragnesh Yashwantsinh Bharpoda and his family. They already own a lot of shares – almost all of them! After the IPO, they’ll still own around 71.45% of the company.

Gujarat Kidney provides healthcare in many places across Gujarat, India. They have seven big hospitals and four pharmacies. They treat a lot of different illnesses, like kidney problems, heart problems, and broken bones.

Their income comes from different sources: the government, insurance companies, and people who pay directly. In the first three months of the current year (Q1 FY2026), they made Rs 4.84 crore in profit and earned Rs 15.26 crore in sales.

Before the IPO, the company raised Rs 100.01 crore from big investors. This helped give them a good start with their business.

Ultimately, the success of Gujarat Kidney and Super Speciality hinges on effectively utilizing the funds raised and delivering on its healthcare promises.